Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.81)
# 3,296
Out of 5,152 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $28.96 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $30.28 | +127.05% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $1.85 | +278.38% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.79 | +1,792.74% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $360 | $1.17 | +30,669.23% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $91.46 | -61.73% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $22.20 | +125.23% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $2,470 → $1,520 | $5.75 | +26,334.78% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $9.99 | +951.05% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $40.89 | -29.08% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $5.49 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $28.96
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $30.28
Upside: +127.05%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $1.85
Upside: +278.38%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.79
Upside: +1,792.74%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $360
Current: $1.17
Upside: +30,669.23%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $91.46
Upside: -61.73%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $22.20
Upside: +125.23%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $2,470 → $1,520
Current: $5.75
Upside: +26,334.78%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $9.99
Upside: +951.05%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $40.89
Upside: -29.08%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $5.49
Upside: -